Abbott Laboratories
ABT
$102.32+1.80%
Delayed · as of Oct 22, 2026, 2:00 PM ET
Mkt cap
$154.15B
EV/Sales
3.58
P/E ratio
N/A
FY2025 Revenue
$44.33B
EPS (9mo ended 2025-09-30)
$2.70
Gross Margin (FY2025)
56.42%
Profit Margin (FY2025)
14.72%
Beta
N/A
Div yield
2.69%
Sector
Healthcare
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B.
Use this ABT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ABT income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Abbott Laboratories (ABT) is a medical devices company in the Healthcare sector.
Latest cached Abbott Laboratories (ABT) revenue for Dec 31, 2025 was $44.33B. Net income was $6.52B. Statements: https://lician.com/financials/abt
Abbott Laboratories (ABT) market capitalization is $154.15B on the latest cached snapshot.
Abbott Laboratories (ABT) cached previous close $100.51; day range $99.91 – $102.69; volume 4,949,519. Session quote: https://lician.com/quote/abt
Abbott Laboratories (ABT) latest cached earnings event is "ABT earnings" on Oct 21, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ABT filing is 8-K · Oct 21, 2026. Filings: https://lician.com/sec/abt